Trending Articles

article thumbnail

In children, Covid is tied to higher risk of type 2 diabetes 

STAT

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age.  An observational study published Monday in JAMA Network Open found that children and adolescents were one-and-a-half times more likely to be diagnosed with the metabolic disorder in the months after having Covid-19 compared to similar kids who weathered other respiratory infections.

Diabetes 336
article thumbnail

AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential

PharmaVoice

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: SalioGen Therapeutics hit by layoffs, as gene-editing biotechs continue to struggle

STAT

SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling back its ambitions, according to a person familiar with the situation and employee posts on social media. It is the latest in a series of retrenchments by high-profile gene-editing companies. A spokesperson for SalioGen declined to comment.

350
350
article thumbnail

The 2024 PharmaVoice 100

PharmaVoice

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

363
363
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Baxter medicines in short supply after hurricane hits plant

pharmaphorum

Damage to a Baxter manufacturing facility caused by Hurricane Helene, which rolled across the east US a couple of weeks ago, has led to shortages in some critical medicines.The plant in North Cove, North Carolina, was severely affected by flooding and had to be shut down at the end of September. It is Baxter's biggest manufacturing site and is also the largest supplier of intravenous and peritoneal dialysis solutions to the US market.

103
103
article thumbnail

Sanofi may have found a buyer for its consumer health business

BioPharma Dive

The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD&R, in a deal that reportedly could be worth more than $16 billion.

111
111

More Trending

article thumbnail

STAT+: In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list

STAT

The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs.  The decision, disclosed in a court filing, marked a stark reversal.

article thumbnail

‘It’s been hard to watch.’ A noted epidemiologist talks H5N1 and the U.S.’s fragmented response

PharmaVoice

Katelyn Jetelina, well known for her newsletter “Your Local Epidemiologist,” digs into the H5N1 outbreak, the public health response and what’s next for vaccinations.

Vaccines 306
article thumbnail

Sanofi in talks to sell stake in consumer health spinout

pharmaphorum

Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially.The French pharma group confirmed this morning that it has entered into talks with US-based Clayton Dubilier & Rice to sell a controlling 50% stake in the unit for what has been estimated by Reuters to be in the region of €15 billion ($16.4 billion).

105
105
article thumbnail

Ex-Pfizer execs ‘threatened’ for supporting plans to shake up company, Starboard says

BioPharma Dive

In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.

112
112
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Capsules of controversy: India’s growing appetite for dietary supplements

Express Pharma

The Food Safety and Standards Authority of India (FSSAI) uncovered a rather disturbing trend last year. A nationwide enforcement drive revealed that over 15 per cent of tested health supplement samples failed to meet regulatory standards. This revelation highlights the growing pains of a sector that promises health benefits to millions of consumers.

article thumbnail

Men won all the science Nobels this year. There’s an even bigger problem.

STAT

Since the Nobel Prizes were created in 1901, just 24 women have received awards in the sciences. This year, that number stayed the same: All seven laureates in physics , chemistry , and physiology or medicine were men.  Some scientists have expressed frustration about the lack of women in this year’s awardees, particularly the omission of two women who contributed to the work honored for the prize in physiology or medicine.

363
363
article thumbnail

GSK asthma hope depemokimab works in second indication

pharmaphorum

GSK's six-monthly IL-5 inhibitor depemokimab clears two phase 3 trials in chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication

98
article thumbnail

NASP, THE GAYLORD, AND FEELING SMALL

The Honest Apothecary

The National Association of Specialty Pharmacy (NASP) held their annual conference at the Gaylord Opryland Hotel in Nashville, TN this year. This post is about my experience at this event, and in particular, the feeling of being small and the benefit that has. The conference ran from Sunday October 6 to Wednesday October 9, 2024. […] The post NASP, THE GAYLORD, AND FEELING SMALL appeared first on The Honest Apothecary.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

CDSCO committee recommends Wockhardt’s novel antibiotic Miqnaf for CABP treatment

Express Pharma

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has provided a recommendation for Wockhardt’s novel antibiotic Miqnaf (nafithromycin) for the treatment of Community-Acquired Bacterial Pneumonia (CABP) in adults. The SEC recommendation is based on a comprehensive review of the product dossier, which includes non-clinical, US/EU Phase 1, Global Phase 2, and India Phase 3 clinical studies conducted over the last 15 years.

95
article thumbnail

Opinion: Encampment sweeps threaten homeless people’s health

STAT

Recently, California Gov. Gavin Newsom granted $130.7 million for local governments addressing homelessness, including clearing encampments. It comes in the wake of  a June Supreme Court ruling that gave cities full authority to implement and enforce policies that would allow them to clear encampments as they see fit. In early August, Newsom was even filmed removing homeless people’s belongings from public view in Mission Hills in Los Angeles County.

Cart Fill 361
article thumbnail

As AI transforms drug development, biotechs might not need as much Big Pharma support

PharmaVoice

Small biotechs are making gains with AI drug development, and their advantages may help some push ahead without Big Pharma.

article thumbnail

Scholar Rock preps filings after SMA antibody clears trial

pharmaphorum

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings in early 2025.The stock rocketed 362% after the announcement, taking Scholar Rock's market cap above $2.7 billion, as analysts started to talk about a blockbuster sales opportunity for the selective myostatin inhibitor.

111
111
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Concern over ‘incorrect and misleading’ pharmacy figures

The Pharmacist

Concern has been raised over what have been described as 'incorrect and misleading' figures released today by the NHS Business Services Authority (NHSBSA) which suggest a record number of active dispensing contractors in several years. New data published by the NHSBSA claim that 2023/24 saw the 'highest number of active dispensing contractors since 2015/16'.

110
110
article thumbnail

University of Central Lancashire partners with Brinton Healthcare UK to explore nanoparticle technology for skin disease treatment

Express Pharma

The University of Central Lancashire (UCLan) has signed a Memorandum of Understanding (MoU) with Brinton Healthcare UK to explore the use of nanoparticle technology in the treatment of skin diseases. The research, led by Professor of Pharmaceutical Technology and Drug Delivery Kamalinder Singh, will investigate innovative solutions for dermatological therapies using topical nanocarriers.

93
article thumbnail

As MFP Approaches, Transparency Is More Important Than Ever

Drug Channels

Today’s guest post comes from Angie Franks, Chief Executive Officer of Kalderos. Angie discusses how the Maximum Fair Price provision of the Inflation Reduction Act of 2022 will challenge providers, pharmacies, and manufacturers. She explains how Kalderos’ Truzo platform could reduce duplicate claims and address compliance issues. To learn more, register for Kalderos’ October 25 webinar Cracking the MFP Code: How Flexible Technology Helps You Navigate an Evolving Landscape.

98
article thumbnail

UK celeb seeks funds to challenge NICE's Enhertu verdict

pharmaphorum

Media personality Nadia Sawalha is heading a fundraising effort to launch an appeal against NICE's recent rejection of a breast cancer therapy Enhertu.

110
110
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Community pharmacy repeat prescription review service ‘should be explored’

The Pharmacist

A commissioned 'repeat prescription review' service in community pharmacy should be explored to improve medicines adherence and patient understanding, the Royal Pharmaceutical Society (RPS) and Royal College of GPs (RCGP) have suggested. The recommendation comes as part of a new repeat prescribing toolkit, in what is believed to be the first guidance of its kind […] The post Community pharmacy repeat prescription review service ‘should be explored’ appeared first on The Pharmacist.

article thumbnail

Alkem signs agreement with US-based Sonnet BioTherapeutics to develop, commercialise its drug candidate for diabetic peripheral neuropathy in India

Express Pharma

Alkem Laboratories, has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings to develop, manufacture and commercialise the drug candidate SON-080 for the treatment of diabetic peripheral neuropathy in India. SON-080 is Sonnet’s proprietary version of “atexakin alfa”. It has shown encouraging data in phase 1b clinical trial.

article thumbnail

As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle

STAT

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire. Last week, the Food and Drug Administration declared an end to the shortage of Eli Lilly’s tirzepatide, sold under the brand name Mounjaro for diabetes and Zepbound for obesity. The move was a clear warning to compounders that they can no longer make copycat versions of the drugs — a process that is only permitted when the medications are on

article thumbnail

EMA publishes EU strategy to 2028

European Pharmaceutical Review

A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). Revised strategy – adapting to change The draft strategy covers the following focus areas up to 2028: Accessibility to support pathways for medicine access in the EU Leveraging data, digitalisation and artificial intelligen

98
article thumbnail

Lawmaker asks FTC to probe Novo/Catalent deal

pharmaphorum

US Senator Elizabeth Warren asks FTC to scrutinise $16.5bn Novo Holdings/Catalent merger and sale of manufacturing plants to Novo Nordisk.

114
114
article thumbnail

Covid inquiry: Pharmacist lays bare difficulties faced by sector

The Pharmacist

A pharmacist has given a first-hand account of the difficult experiences he and pharmacy teams faced during the Covid-19 pandemic, as part of an independent inquiry into the UK’s response to the outbreak. From major issues with ordering and storing stock, working night shifts to keep up with demands, and sourcing their own personal protective […] The post Covid inquiry: Pharmacist lays bare difficulties faced by sector appeared first on The Pharmacist.

105
105
article thumbnail

Biocon Biologics report explores pathways to increase biosimilar adoption in low- and middle-income countries

Express Pharma

Biocon Biologics, a global biosimilars company, has released the findings of a study focused on improving the adoption of biosimilars in low- and middle-income countries (LMICs). The study, commissioned by Biocon Biologics and developed in collaboration with Clarivate, highlights strategies to expand access to affordable healthcare solutions through biosimilars.

article thumbnail

STAT+: Nobel-winning AI was built on open science. Will the quest for profits quash collaboration?

STAT

The 2024 Nobel Prizes will be remembered as the year that artificial intelligence took the awards by storm. The physics prize this week was awarded to two scientists, John Hopfield and Geoffrey Hinton, who laid the groundwork for the field of machine learning. The next day, the chemistry prize went to a trio of researchers whose work built on Hopfield and Hinton’s principles, developing AI models that predict the structure of proteins and design entirely new ones.

354
354
article thumbnail

AstraZeneca licenses CSPC’s cardiovascular drug in $2 billion deal

Outsourcing Pharma

The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical Group for access to an experimental small molecule treatment for dyslipidemia.

98
article thumbnail

Ono, Boehringer add to cancer pipelines with licensing deals

pharmaphorum

Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma, respectively.Ono's deal with South Korean antibody-drug conjugate (ADC) specialist LigaChem is worth up to $700 million and covers a license to a preclinical-stage candidate for solid tumours, as well as an R&D collaboration to seek out other ADC candidates.

100
100